Olink Proteomics Webinar15th August
“Proteogenomic strategies to advance drug development and precision medicine”
TATAA Biocenter’s partner Olink Proteomics are sponsoring a Science/AAAS-hosted webinar: Gain new insights into how proteomics and genomics are now increasingly joining forces to improve the clinical utility of protein biomarkers and to enhance drug development strategies.
When? Wednesday September 6, 2017 at 12:00 pm U.S. Eastern Time/18:00 Central European Time
This free event will feature presentations from Professor Ulf Gyllensten (Uppsala University) & Dr. Anders Mälarstig (Pfizer Sweden)
During the webinar, the speakers will:
- Discuss how covariates (genetic, environmental, and clinical) can affect the levels of potential biomarkers
- Explore the use of covariate modeling to establish personally normalized plasma protein profiles (PNPPP) to reduce non-disease-related variation and maximize clinical potential
- Describe how protein quantitative trait loci (pQTLs) can provide insights into disease biology and improve the efficiency of drug development
- Answer your questions live during the broadcast!